Protagonist Therapeutics Inc. logo

Protagonist Therapeutics Inc. (PTGX)

Market Closed
1 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
146. 49
-1.26
-0.8528%
After Hours
$
152. 03
+5.54 +3.7818%
9.5B Market Cap
- P/E Ratio
- Div Yield
534,120 Volume
0.75 Eps
$ 147.75
Previous Close
Add Transaction
Day Range
144.73 150.35
Year Range
54.5 160.81
Want to track PTGX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Protagonist Therapeutics Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
EG
Ethan Gilbert Rialto Wealth Management LLC
5 $613 $750 $137 22.35%
DN
Daniel Newman Noble Wealth Management PBC
8 $981 $1,093.12 $112.12 11.43%
RFL
Rossby Financial LLC Rossby Financial LLC
9 $933 $1,229.76 $296.76 31.81%
RS
Ruza Susnik Triglav Investments d.o.o.
3,000 $367,740 $450,000 $82,260 22.37%
GFM
GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.
1,353 $66,733.67 $197,362.11 $130,628.44 195.75%
JCB
John Ciaran Burns Universal-Beteiligungs- und Servicegesellschaft mbH
102,002 $6.95M $14.01M $7.05M 101.41%
Ameriflex Group Inc.
Ameriflex Group Inc. Ameriflex Group Inc.
11 $1,348 $1,706.1 $358.1 26.57%
KGL
Kilter Group LLC Kilter Group LLC
4 $222 $600 $378 170.27%
Nicole Reese
Nicole Reese WPG Advisers LLC
107 $7,159.23 $14,693.24 $7,534.01 105.23%